| Financial Year |
March 31 2023 |
| Monetary Funds |
690,914,181.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
219,610,753.23 |
| Accounts Receivable |
1,051,710,976.71 |
| Advances to Suppliers |
13,960,243.91 |
| Other Receivables |
22,234,230.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
330,108,206.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,443,158.74 |
| Total Current Assets |
2,567,496,308.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
185,409,379.43 |
| Investment Properties |
29,915,324.85 |
| Fixed Assetes |
522,291,868.76 |
| Under-construction Projects |
22,157,025.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,641,014.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,582,945.42 |
| Deferred Income Tax Assets |
20,054,761.37 |
| Other Non-Current Assets |
21,366,739.12 |
| Sub-Total of Non-Current Assets |
891,843,630.25 |
| Total Assets |
3,459,339,938.49 |
| Short-Term Loans |
610,314,056.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,679,462.01 |
| Accounts Payable |
117,380,107.96 |
| Accounts Received In Advance |
84,541.08 |
| Employee Compensation Payable |
2,617,097.13 |
| Taxes Payable |
4,484,545.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,389,521.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,745,043.44 |
| Other Current Liabilities |
393,853,843.05 |
| Sub-Total of Current Liabilities |
1,260,562,803.46 |
| Long-term Loans |
47,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
439,611.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,407,921.55 |
| Total Liabilities |
1,351,970,725.01 |
| Paid-In Capital(Or Share Stock) |
621,527,586.00 |
| Capital Surplus |
1,129,142,786.23 |
| Surplus Reserve |
50,181,760.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
310,015,674.78 |
| Minority Stockholder's Interest |
-976,151.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,108,345,365.24 |
| Owner's Equity（Stockholder's Equity） |
2,107,369,213.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,459,339,938.49 |
